Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to -$16.8 million.

  • SRx Health Solutions' Income towards Parent Company fell 52783.58% to -$16.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$21.8 million, marking a year-over-year decrease of 1658.9%. This contributed to the annual value of $4.2 million for FY2024, which is 11841.02% up from last year.
  • SRx Health Solutions' Income towards Parent Company amounted to -$16.8 million in Q2 2025, which was down 52783.58% from -$964000.0 recorded in Q1 2025.
  • Over the past 5 years, SRx Health Solutions' Income towards Parent Company peaked at $24.8 million during Q2 2021, and registered a low of -$24.4 million during Q4 2022.
  • Its 5-year average for Income towards Parent Company is -$4.7 million, with a median of -$3.8 million in 2023.
  • In the last 5 years, SRx Health Solutions' Income towards Parent Company soared by 29820.8% in 2021 and then plummeted by 52783.58% in 2025.
  • SRx Health Solutions' Income towards Parent Company (Quarter) stood at -$5.1 million in 2021, then tumbled by 379.28% to -$24.4 million in 2022, then surged by 39.7% to -$14.7 million in 2023, then skyrocketed by 72.89% to -$4.0 million in 2024, then plummeted by 322.45% to -$16.8 million in 2025.
  • Its last three reported values are -$16.8 million in Q2 2025, -$964000.0 for Q1 2025, and -$4.0 million during Q4 2024.